RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 108 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 4.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,807,000 | -0.8% | 662,056 | +20.4% | 0.02% | 0.0% |
Q1 2017 | $1,821,000 | +97.3% | 550,000 | +41.9% | 0.02% | +100.0% |
Q4 2016 | $923,000 | -68.8% | 387,697 | -51.8% | 0.01% | -62.5% |
Q3 2016 | $2,954,000 | +32.5% | 805,000 | -19.5% | 0.03% | +39.1% |
Q2 2016 | $2,229,000 | +7.2% | 999,700 | 0.0% | 0.02% | +53.3% |
Q1 2016 | $2,079,000 | +29.8% | 999,700 | +89.1% | 0.02% | +50.0% |
Q4 2015 | $1,602,000 | – | 528,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |